Prognostic impact of XPO1 mutations in metastatic non-small cell lung cancer (NSCLC).

被引：1

作者：

Asad, Mohammad Fahad B.

Al Hallak, Mohammed Najeeb

Sukari, Ammar

Baca, Yasmine

Xiu, Joanne

Mamdani, Hirva

Uprety, Dipesh

Kim, Chul

Xia, Bing

Liu, Stephen V.

Nieva, Jorge J.

Lopes, Gilberto

Borghaei, Hossein

Demeure, Michael J.

Raez, Luis E.

Ma, Patrick C.

Puri, Sonam

Korn, Wolfgang Michael

Azmi, Asfar S.

Nagasaka, Misako

机构：

[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[2] Wayne State Univ, Karmanos Canc Inst, Detriot, MI USA

[3] Caris Life Sci, Phoenix, AZ USA

[4] Barbara Ann Karmanos Canc Inst, Detroit, MI USA

[5] Karmanos Canc Inst, Detroit, MI USA

[6] Room 417,B,Second Floor, Washington, DC USA

[7] USC Keck Sch Med, Norris Comprehens Canc Ctr, Div Oncol, Los Angeles, CA USA

[8] Georgetown Univ, Dept Hematol & Oncol, Washington, DC USA

[9] Univ Southern Calif, Los Angeles, CA 90007 USA

[10] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[11] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[12] Translat Genom Res Inst, Phoenix, AZ USA

[13] Mem Canc Inst, Miami, FL USA

[14] Penn State Hlth Milton S Hershey Med Ctr, Penn State Canc Inst, Hershey, PA USA

[15] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.e20533

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e20533

引用

页数：3